Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 56

1.

To treat or not to treat: Sequential individualized treatment evaluation in relapsing multiple sclerosis.

Bsteh G, Hegen H, Dosser C, Auer M, Berek K, Wurth S, Zinganell A, Di Pauli F, Deisenhammer F, Berger T.

Mult Scler Relat Disord. 2019 Dec 23;39:101908. doi: 10.1016/j.msard.2019.101908. [Epub ahead of print]

PMID:
31896060
2.

Serum neurofilament light levels correlate with change of olfactory function in multiple sclerosis.

Bsteh G, Berek K, Hegen H, Buchmann A, Voortman MM, Auer M, Wurth S, Zinganell A, Di Pauli F, Deisenhammer F, Khalil M, Berger T.

Mult Scler J Exp Transl Clin. 2019 Nov 5;5(4):2055217319885987. doi: 10.1177/2055217319885987. eCollection 2019 Oct-Dec.

3.

Serum hepcidin levels in multiple sclerosis.

Bsteh G, Haschka D, Tymoszuk P, Berek K, Petzer V, Hegen H, Wurth S, Auer M, Zinganell A, Pauli FD, Deisenhammer F, Weiss G, Berger T.

Mult Scler J Exp Transl Clin. 2019 Nov 4;5(4):2055217319885984. doi: 10.1177/2055217319885984. eCollection 2019 Oct-Dec.

4.

Serum neurofilament levels correlate with retinal nerve fiber layer thinning in multiple sclerosis.

Bsteh G, Berek K, Hegen H, Teuchner B, Buchmann A, Voortman MM, Auer M, Wurth S, Zinganell A, Di Pauli F, Deisenhammer F, Khalil M, Berger T.

Mult Scler. 2019 Oct 31:1352458519882279. doi: 10.1177/1352458519882279. [Epub ahead of print]

PMID:
31668116
5.

Dataset for worldwide survey of cerebrospinal total protein upper reference values.

Bourque PR, Brooks J, Warman-Chardon J, Hegen H, Deisenhammer F, McCudden CR, Breiner A.

Data Brief. 2019 Mar 7;23:103760. doi: 10.1016/j.dib.2019.103760. eCollection 2019 Apr.

6.

Conversion and reversion of anti-John Cunningham virus antibody serostatus: A prospective study.

Auer M, Hegen H, Sellner J, Oppermann K, Bsteh G, Di Pauli F, Berger T, Deisenhammer F.

Brain Behav. 2019 Jul;9(7):e01332. doi: 10.1002/brb3.1332. Epub 2019 Jun 6.

7.

Free light chains in the cerebrospinal fluid. Comparison of different methods to determine intrathecal synthesis.

Hegen H, Walde J, Milosavljevic D, Aboulenein-Djamshidian F, Senel M, Tumani H, Deisenhammer F, Presslauer S.

Clin Chem Lab Med. 2019 Sep 25;57(10):1574-1586. doi: 10.1515/cclm-2018-1300.

PMID:
31112501
8.

The clinical significance of single or double bands in cerebrospinal fluid isoelectric focusing. A retrospective study and systematic review.

Hegen H, Zinganell A, Auer M, Deisenhammer F.

PLoS One. 2019 Apr 15;14(4):e0215410. doi: 10.1371/journal.pone.0215410. eCollection 2019.

9.

A Survey of Cerebrospinal Fluid Total Protein Upper Limits in Canada: Time for an Update?

Bourque PR, McCudden CR, Warman-Chardon J, Brooks J, Hegen H, Deisenhammer F, Breiner A.

Can J Neurol Sci. 2019 May;46(3):283-286. doi: 10.1017/cjn.2019.12. Epub 2019 Mar 27.

PMID:
30915935
10.

Impairment of odor discrimination and identification is associated with disability progression and gray matter atrophy of the olfactory system in MS.

Bsteh G, Steiger R, Tuovinen N, Hegen H, Berek K, Wurth S, Auer M, Di Pauli F, Gizewski ER, Deisenhammer F, Berger T, Scherfler C.

Mult Scler. 2019 Mar 21:1352458519838205. doi: 10.1177/1352458519838205. [Epub ahead of print]

PMID:
30895860
11.

Adult CSF total protein upper reference limits should be age-partitioned and significantly higher than 0.45 g/L: a systematic review.

Breiner A, Moher D, Brooks J, Cheng W, Hegen H, Deisenhammer F, McCudden CR, Bourque PR.

J Neurol. 2019 Mar;266(3):616-624. doi: 10.1007/s00415-018-09174-z. Epub 2019 Jan 8.

PMID:
30617996
12.

Pregnancy and multiple sclerosis in the DMT era: A cohort study in Western Austria.

Bsteh G, Algrang L, Hegen H, Auer M, Wurth S, Di Pauli F, Deisenhammer F, Berger T.

Mult Scler. 2020 Jan;26(1):69-78. doi: 10.1177/1352458518816614. Epub 2018 Dec 3.

PMID:
30507345
13.

Smelling multiple sclerosis: Different qualities of olfactory function reflect either inflammatory activity or neurodegeneration.

Bsteh G, Berek K, Hegen H, Teuchner B, Auer M, Wurth S, Di Pauli F, Deisenhammer F, Berger T.

Mult Scler. 2020 Jan;26(1):57-68. doi: 10.1177/1352458518814113. Epub 2018 Nov 22.

PMID:
30465490
14.

Admission diagnoses of patients later diagnosed with autoimmune encephalitis.

Baumgartner A, Rauer S, Hottenrott T, Leypoldt F, Ufer F, Hegen H, Prüss H, Lewerenz J, Deisenhammer F, Stich O.

J Neurol. 2019 Jan;266(1):124-132. doi: 10.1007/s00415-018-9105-3. Epub 2018 Nov 12.

PMID:
30421340
15.

Adult CSF total protein: Higher upper reference limits should be considered worldwide. A web-based survey.

Bourque PR, Breiner A, Moher D, Brooks J, Hegen H, Deisenhammer F, McCudden CR.

J Neurol Sci. 2019 Jan 15;396:48-51. doi: 10.1016/j.jns.2018.10.033. Epub 2018 Nov 3.

PMID:
30419367
16.

Impact of Disease-Modifying Treatments on the Longitudinal Evolution of Anti-JCV Antibody Index in Multiple Sclerosis.

Hegen H, Walde J, Bsteh G, Auer M, Wurth S, Zinganell A, Di Pauli F, Deisenhammer F, Berger T.

Front Immunol. 2018 Oct 25;9:2435. doi: 10.3389/fimmu.2018.02435. eCollection 2018.

17.

Utility of Two-Dimensional Difference Gel Electrophoresis in Diagnosis of Multiple Sclerosis.

Auer M, Hegen H, Rudzki D, Golderer G, Deisenhammer F.

Diagnostics (Basel). 2018 Jul 5;8(3). pii: E44. doi: 10.3390/diagnostics8030044.

18.

Autoantibodies against neuronal surface proteins in spontaneous subarachnoid and intracerebral haemorrhage.

Hegen H, Helbok R, Kofler M, Pfausler B, Schiefecker A, Schmutzhard E, Beer R.

BMC Neurol. 2018 Jun 28;18(1):89. doi: 10.1186/s12883-018-1097-1.

19.

Transient impairment of olfactory threshold in acute multiple sclerosis relapse.

Bsteh G, Hegen H, Ladstätter F, Berek K, Amprosi M, Wurth S, Auer M, Di Pauli F, Deisenhammer F, Lutterotti A, Berger T.

Mult Scler Relat Disord. 2018 Jul;23:74-77. doi: 10.1016/j.msard.2018.05.006. Epub 2018 May 26.

PMID:
29783156
20.

Cerebrospinal fluid free light chains as diagnostic biomarker in neuroborreliosis.

Hegen H, Milosavljevic D, Schnabl C, Manowiecka A, Walde J, Deisenhammer F, Presslauer S.

Clin Chem Lab Med. 2018 Jul 26;56(8):1383-1391. doi: 10.1515/cclm-2018-0028.

PMID:
29648995

Supplemental Content

Loading ...
Support Center